2017-4

More documents

Recommendations

Info

SUBJECT INDEX 2017Salmonella / Salmonella, 93Campylobacter / Campylobacter, 93Listeria monocytogenes / Listeria monocytogenes, 93Febrile neutropenia / Febril nötropeni, 109, 167, 254, 340Candida / Candida, 109Immune response inflammatory syndrome / İmmün yanıtenflamatuvar sendromu, 109Allogeneic hematopoietic stem cell transplantation /Allojeneik hematopoietik kök hücre transplantasyonu, 159Cytomegalovirus / Sitomegalovirüs, 159Graft-versus-host disease / Graft versus host hastalığı, 159Taiwan / Tayvan, 159Neutrophil / Nötrofil, 167CD64 / CD64, 167Bacteremia / Bakteriyemi, 167, 254Diagnostic parameter / Diyagnostik parametre, 167Acute compartment syndrome / Akut kompartman sendromu, 179Inflammation / Enflamasyon, 179Immune deficiency / İmmün yetmezlik, 179IL-6 / IL-6, 254IL-8 / IL-8, 254IL-10 / IL-10, 254Leishman-Donovan body / Leishman-Donovan cismi, 266Bone marrow aspirate smear / Kemik iliği aspirasyonu yayması, 266Microscopic image / Mikroskobik görüntü, 266Acute myeloid leukemia / Akut miyeloid lösemi, 103, 192, 300, 307, 340Pediatric leukemia / Çocuk çağı lösemileri, 340Infection / Enfeksiyon, 340Leukoagglutination / Lökoaglütinasyon, 354Cold agglutinin / Soğuk aglütinin, 354Mycoplasma pneumoniae / Mycoplasma pneumoniae, 354Eosinophilia / Eozinofili, 354Pseudoleukopenia / Psödolökopeni, 354Sickle cell anemia / Orak hücreli anemi, 196, 358Osteomyelitis / Osteomiyelit, 358Salmonella typhi / Salmonella typhi, 358Cholangitis / Kolanjit, 359Döhle bodies / Döhle cisimciği, 359May-Hegglin anomaly / May-Hegglin anomalisi, 359Imatinib mesylate / İmatinib mesilat, 362Interstitial pneumonitis / İnterstisyel pnömonitis, 362Chronic myeloid leukemia / Kronik miyeloid lösemi, 362Nilotinib / Nilotinib, 137, 197, 362Tuberculosis / Tüberküloz, 362Leishmaniasis / Layşmanyazis, 380Bone marrow / Kemik iliği, 380Aspirate / Aspirasyon, 380Smear / Yayma, 380Antibody / Antikor, 380LymphomaDiagnosis of lymphoma / Lenfoma tanısı, 81World Health Organization lymphoma classification / Dünya SağlıkÖrgütü lenfoma sınıflaması, 81Discrepancies in diagnosis / Tanı tutarsızlıkları, 81Hematopathology / Hematopatoloji, 81Bing-Neel syndrome / Bing-Neel sendromu, 186Waldenström’s macroglobulinemia /Waldenström makroglobulinemisi, 186Central nervous system / Merkezi sinir sistemi, 186MYD88 L265P mutation / MYD88 L265P mutasyonu, 186Cerebrospinal fluid / Beyin-omurilik sıvısı, 186Leukemia / Lösemi, 89, 109, 126, 186, 190Richter’s syndrome / Richter sendromu, 188Flow cytometry / Akım sitometri, 188Chronic lymphocytic leukemia / Kronik lenfositik lösemi, 188CD5-positive / CD5- pozitif, 188Diffuse large B-cell lymphoma / Diffüz büyük B-hücreli lenfoma, 188Mycosis fungoides / Mikozis fungoides, 194Ichthyosiform / İktiyotik, 194Sezary syndrome / Sezary sendromu, 194Anaplastic / Anaplastik, 194CD3/TCR / CD3/TCR, 194MicroRNA-155 / MikroRNA-155, 207Non-Hodgkin lymphoma / Hodgkin dışı lenfoma, 207, 378, 381Prognosis / Prognoz, 126, 143, 207Hodgkin’s lymphoma / Hodgkin lenfoma, 272Metastatic adenocarcinoma / Metastatik adenokarsinom, 272Reed-Sternberg cells / Reed-Sternberg hücreleri, 272PET/CT / PET/BT, 272Follicular lymphoma / Foliküler lenfoma, 364Extranodal / Ekstranodal, 364Prostatic involvement / Prostat Tutulumu, 364T-cell neoplasms / T hücreli neoplazmlar, 378Oncogenes / Onkogenler, 378T-cell mediated immunity / T hücre aracılı immünite, 378miR-155 / miR-155, 381Prognostic value / Prognostik değer, 381Molecular HematologyTrisomy 6 / Trizomi 6, 103Acute myeloid leukemia / Akut miyeloid lösemi, 103, 192, 340, 300, 307Breast cancer / Meme kanseri, 103Thalassemia / Talasemi, 105Variant / Varyant, 105Genetic counseling / Genetik danışmanlık, 105Prenatal diagnosis / Prenatal tanı, 105Beta globin gene / Beta globin geni, 105Turkish / Türk, 105Monosomal karyotype / Monozomal karyotip, 126Prognosis / Prognoz, 126, 143, 207Leukemia / Lösemi, 89, 109, 126, 186, 190Chronic myeloid leukemia / Kronik miyeloid lösemi, 16, 137, 197Nilotinib / Nilotinib, 137, 197, 362Fertility / Doğurganlık, 137Mouse / Fare, 137Gonads / Gonad, 137Methotrexate / Metotreksat, 143Toxicity / Toksisite, 143Folate-related gene polymorphisms / Folat-ilişkili genpolimorfizmleri, 143Acute lymphoblastic leukemia / Akut lenfoblastik lösemi, 40, 151, 366Glucocorticoid receptor gene / Glukokortikoid reseptör geni, 151BclI and N363S polymorphisms / BclI ve N363S polimorfizmleri, 151TET2 / TET2, 174ASXL1 / ASXL1, 174IDH1 / IDH1, 174IDH2 / IDH2, 174
SUBJECT INDEX 2017Single nucleotide polymorphisms / Tek nükleoitid polimorfizm, 174Ph-negative myeloproliferative neoplasms /Ph-negatif Miyeloproliferatif neoplaziler, 174Bing-Neel syndrome / Bing-Neel sendromu, 186Waldenström’s macroglobulinemia / Waldenströmmakroglobulinemisi, 186Central nervous system / Merkezi sinir sistemi, 186MYD88 L265P mutation / MYD88 L265P mutasyonu, 186Cerebrospinal fluid / Beyin-omurilik sıvısı, 186Leukemia / Lösemi, 89, 109, 126, 186, 190Adult / Erişkin, 196, 366Sickle cell anemia / Orak hücreli anemi, 196, 358Genetic counseling / Genetik danışmanlık, 196Transplantation / Transplantasyon, 102, 196Myelodysplastic syndromes / Miyelodisplastik sendromlar, 200Telomere-binding proteins / Telomer-bağlayıcı proteinler, 200Reverse transcription-polymerase chain reaction /Ters transkripsiyon-polimeraz zincir reaksiyonu, 200International Prognostic Scoring System /Uluslararası Prognoz Skorlama Sistemi, 200World Health Organization Prognostic Scoring System /Dünya Sağlık Örgütü Prognoz Skorlama Sistemi, 200MicroRNA-155 / MikroRNA-155, 207Non-Hodgkin lymphoma / Hodgkin dışı lenfoma, 207, 378, 381Immunoregulatory effect / Bağışıklık baskılayıcı etki, 213Co-culture / Ko-kültür, 213Mesenchymal stem cells / Mezenkimal kök hücre, 213T cells / T hücre, 213Thalassemia / Talasemi, 258Sickle/β-thalassemia / Orak/β talasemi, 258Codon / Kodon, 258Genotype / Genotip, 258Phenotype / Fenotip, 258, 374Wolman disease / Wolman hastalığı, 264Hemophagocytic lymphohistiocytosis /Hemafagositik lenfohistiyositozis, 264Hemophagocytosis / Hemofagositoz, 264Hemophilia A / Hemofili A, 278FVIII gene / FVIII geni, 278Intron 1 / İntron 1, 278Polymerase chain reaction / Polimeraz zincirleme reaksiyonu, 278Pakistan / Pakistan, 278Essential thrombocythemia / Esansiyel trombositemi, 360Primary myelofibrosis / Primer miyelofibroz, 124, 360Calreticulin / Kalretikulin, 360EZH2 / EZH2, 366T-cell / T-hücre, 366Abnormal hemoglobins / Anormal hemoglobinler, 372Hemoglobin San Diego / Hemoglobin San Diego, 372Hemoglobin variant / Hemoglobin varyantı, 372Para-Bombay / Para-Bombay, 374FUT1 gene / FUT1 geni, 374Blood transfusion / Kan transfüzyonu, 374Myopathy / Miyopati, 376Lactic acidosis / Laktik asidoz, 376Sideroblastic anemia / Sideroblastik anemi, 376miR-155 / miR-155, 381Prognostic value / Prognostik değer, 381Gene mutation / Gen mutasyonu, 300FLT3 / FLT3, 300NPM1 / NPM1, 300Multiple MyelomaMultiple myeloma / Multipl miyelom, 131, 184, 226, 233, 282Prognostic factors / Prognostik faktörler, 131Serum immunoglobulins / Serum immünglobulin, 131Nephelometric measurement / Nefelometrik ölçüm, 131M-protein / M-protein, 131Myeloma / Miyelom, 89, 181, 182, 352Infection / Enfeksiyon, 181Atlas / Atlas, 181Fracture / Kırık, 181Acquired hemophilia / Edinsel hemofili, 184Factor VIII / Faktör VIII, 184Autoantibody / Otoantikor, 184Coagulation disorder / Koagülasyon bozukluğu, 184CD56 / CD56, 226CD117 / CD117, 226Flow cytometry / Akım sitometri, 226Relapse refractory / Relaps refrakter, 233Bendamustine / Bendamustin, 233Distal arteriovenous fistula / Distal arteriyovenöz fistül, 268Multislice computer tomography / Çok kesitli bilgisayarlı tomografi, 268Hemodialysis / Hemodiyaliz, 268Plasmacytoma / Plazmasitom, 352Intracranial / İntrakraniyal, 352Monoclonal gammopathy of renal significance / Renal önemesahip monoklonal gammopati, 282Plasma cell disorders / Plazma hücre hastalıkları, 282Renal involvement / Böbrek tutulumu, 282Kidney / Böbrek, 282Cast nephropathy / Kast nefropati, 282Myelodysplastic SyndromesRefractory anemia with ring sideroblasts / Halka sideroblastlı refrakteranemi, 100RARS with thrombocytosis / Trombositoz ile birlikte RARS, 100Myelodysplastic syndrome/myeloproliferative neoplasm with ringsideroblasts and thrombocytosis / Halka sideroblast ve trombositoz ilebirlikte miyelodisplastik sendrom/miyeloproliferatif neoplazi, 100Myelodysplastic syndromes / Miyelodisplastik sendromlar, 200Telomere-binding proteins / Telomer-bağlayıcı proteinler, 200Reverse transcription-polymerase chain reaction / Terstranskripsiyon-polimeraz zincir reaksiyonu, 200International Prognostic Scoring System /Uluslararası Prognoz Skorlama Sistemi, 200World Health Organization Prognostic Scoring System /Dünya Sağlık Örgütü Prognoz SkorlamaSistemi, 200Myeloproliferative DisordersChronic myeloproliferative neoplasms / Kronikmiyeloproliferatif neoplaziler, 27Treatment / Tedavi, 27Survival / Sağkalım, 27JAK2 mutation / JAK2 mutasyonu, 27Primary myelofibrosis / Primer miyelofibroz, 124, 360Internuclear bridging / Nükleuslar arası köprüleşme, 124Erythrocytes / Eritrositler, 124
Page 1 and 2:
Volume 34 Issue 4 December 2017 80
Page 3 and 4:
Contact InformationEditorial Corres
Page 5 and 6:
TURKISH JOURNAL OF HEMATOLOGYINSTRU
Page 7 and 8:
subject may be posited. Do not publ
Page 9 and 10:
the questions. You may copy and pas
Page 11 and 12:
352 Giant Intracranial Solitary Pla
Page 13 and 14:
REVIEWDOI: 10.4274/tjh.2017.0197Tur
Page 15 and 16:
Ünlü ŞM, et al: The Scope of Kid
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Levy I and Tadmor T: Time to Cure H
Page 23 and 24:
Öngören Ş, et al: First-Line Tre
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
RESEARCH ARTICLEDOI: 10.4274/tjh.20
Page 33 and 34:
Rezaei N, et al: FLT3 and NPM1 Muta
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Menteşe A, et al: Serum Anti-Carbo
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Gencer EB, et al: Phenotypical Anal
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Sarıtürk Ç, et al: Visual Inform
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Hsieh C and Rajashekharaiah V, Infl
Page 63 and 64:
Hsieh C and Rajashekharaiah V, Infl
Page 65 and 66:
Page 67 and 68:
Qian H, et al: Antioxidants, Novel
Page 69 and 70: Qian H, et al: Antioxidants, Novel
Page 71 and 72: BRIEF REPORTDOI: 10.4274/tjh.2017.0
Page 73 and 74: Zengin E, et al: Infection-Related
Page 75 and 76: Zengin E, et al: Infection-Related
Page 77 and 78: Yıldıran A, et al: HSC Transplant
Page 79 and 80: Yıldıran A, et al: HSC Transplant
Page 81 and 82: IMAGES IN HEMATOLOGYDOI: 10.4274/tj
Page 87 and 88: LETTERS TO THE EDITORTurk J Hematol
Page 89 and 90: LETTERS TO THE EDITOR Turk J Hemato
Page 113 and 114: AUTHOR INDEX 201734 th Volume Index
Page 115 and 116: AUTHOR INDEX 2017Serkan Güvenç...
Page 117 and 118: SUBJECT INDEX 2017Status epilepticu
Page 119: SUBJECT INDEX 2017Chronic lymphocyt
Page 123 and 124: SUBJECT INDEX 2017Megakaryocytic em
show all

2017-4

Create successful ePaper yourself

Delete template?

Save as template?